To further explore the molecular mechanism whereby C3 regulates PTX resistance in NSCLC, we first examined C3 expression and location in the cytoplasm and nucleus of A549-ORI and A549-PTX cells. This evidence concerns the gene C3 and non-small cell lung carcinoma.